Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here’s my logic:
It is easier to go after one indication at a time because you can compare results against other trial results and data for a given cancer.
How would you structure a trial and pass/fail criterion for some mix of indications/cancers??
Not saying it’s impossible but maybe my mental acuity is currently flagging at 4am in the eastern time zone and the last coffee was drunk many hours ago
Fortune teller spoke with forked tongue.
I thought that was suspicious.
Unfortunately today everyone is lying, really!
The FUDsters haven’t a leg to stand on since their claims are already invalidated by clear facts. The garbage being flung isn’t worth reading at this point.
Not gonna take too long now.
I went to a fortune teller and was told about new major wealth coming my way!
Approval from across the Atlantic incoming shortly, right in the crystal ball!
The funny thing is the fortune telling session was concluded with the statement:
Remember, everyone is lying
There has been multiple forces at work against the success of nwbo for over a decade, and they have had detrimental impacts. Some impacts include being forced to keep raising funds in unfavorable manners and lower share prices.
In order to survive we wound up on the OTC market, which precludes many investment funds from investing, and is a market full of shenanigans by the big dogs of the market.
I have no doubt that given the concrete factual progress that has been achieved, and sitting with a successful phase 3 where every one of the hundreds of previous trials have failed, and at the doorstep of first approval, the share price would be north of $10 by now.
However the real news is spreading and with first approval the treatment, company, and share price, will all begin to reflect true value potential. I say potential because while we have a handle on the GBM market, this is only the beginning and the tip of the huge iceberg of solid tumor cancer indications and potentially non cancer diseases.
So the current share price is not representative of nwbo’s value and imminent impact on the oncology world!
Sky,
Excellent, outstanding post!
A veritable tour de force!
You can stack all the negative narratives together and your post destroys them because your post assembles FACTs together, not opinions!
When nwbo rockets you’ll be a rich friend.
There you go, Longport… feels good don’t it
Lucy the elephant has a long trunk, and long tusks, and the boardwalk there is long, and it’s not too far a drive south from Long Beach Island.
I will miss the Joisey Shore when I’m living in Georgia. Hey maybe if nwbo rockets before next spring I’ll be able to keep the Jersey home or trade it for a condo by the beach! There I go again with my super long optimism
Thermo, their allegedly making up for the small size by volumes and years of rinse and repeat, which by being the “house” in the casino and using loaded dice and marked cards, they ain’t gambling.
Then allegedly rig the games for a bunch of stocks and before you know it they’re making a big score, all imho.
When you play football, send your receivers out long!
In archery, use a long bow!
Don’t say you’re driving out to the Hamptons, you’re going to Long Island!
Long Beach, Lungo (long) Nespresso coffee pods, the Long And Winding Road, long, long, long,……
Got a bit carried away… a long way
Reminds me of The Lemon Song on Lef Zeppelin II
Squeeze that lemon!
BS alert!
Nwbo is focused on first approval of dcvax-L for GBM/rGBM.
Direct and other indications will be added in time and likely with BP participation.
Discussions/collaborations are the necessary conditions in order to reach the necessary and sufficient conditions!
Unless the agreements are arrived at by playing charades, which I highly doubt
Pardon me for jumping in, however since GBM sorely needs advancements toward cures, and keytruda and opdivo need DCVax to provide groundbreaking super advancements in efficacy, and with the early combo data being extraordinarily promising, Merck and Brystol Meyers should get the GBM combinations to those patients first or at least in parallel with other potential indications imo.
Yea, verily! I remember it well.
Cue Maurice Chevalier
Flipper, please don’t let the mal intents win by driving you away with their bs!
They would love to not have your knowledge and intelligence around to help keep them from passing off their propaganda of fabricated negative narratives.
Don’t know if you’re in the UK but keep a stiff upper lip and maintain the front line with us. We need you, and cancer sufferers need you although they might not know it. It’s about more than money, except for the mal intents and paid mercenaries.
I’m pretty sure nwbo previously mentioned getting to approval and then demonstrating the FlaskWorks automation/closed system produces the same vaccine.
It’s possible the more automated production process is catching or caught up but logically I would think you wouldn’t complicate or unnecessarily risk first approval.
That establishes an approved baseline process and vaccine and the automated production can be compared against it while not further delaying availability to patients.
Me thinks you have the makings of a modern day Dickens reminiscent of “it was the best of times it was the worst of times”
It’s nice to see everyone playing much more nicely together keeping the discourse at a more rational basis than last week.
Thanks y’all and GLTA
Yes, that’s what I’m thinking too and BB stated the $201k rev is a net number, which supports your assumptions.
I’m on board with your interpretation of these key statements!
Wasn’t there also an extremely positive statement about partnerships, or is it wishful recall on my part of the 10Q?
Not sure if this applies at outset, however if multiple shifts are used that requires more than a single shift operation.
You have to be ready and hit the road running, so I would venture a few guesses:
Training of the new employees
Bringing up capacity of production lines
Honing processes for demand post approval
Readying supply chain and inventories
Dream do come true! The American dream!
Who needs crypto tokens when we are about to experience something between a 10X to 50X or more appreciation of nwbo!
Stand your ground dstock, it’s all part of the negative narrative propaganda!
The tissue and data banking assets nwbo is building, including potentially an antigen library, would appear to align and create value!
I appreciate witty humor so nice retort, however how they handle the delay might show who’s a truer friend. In the end they should do fine. Btw, I don’t push any investments on anyone and give a disclaimer when I do mention a company.
Lately I’m being asked about Northwest Bio.
The word continues to spread:
I tell you, you tell your friends, they tell their friends, and so on, and so on, and so on, ……
Thank you, I appreciate the information!
Is oatmeal (rolled or steel cut) ok in breakfast meal? The rolled oats prepare more quickly vs steel cut, but is there a significant metabolic response?
The trial and results have been accepted and it is aligned with advances “sponsored “ by the FDA. Further the PIP has been accepted which further validates the trial design.
And the reality is the trial was not messed up and has scientific and moral basis. It’s just the fabrication of negative narratives.
There are multiple reasons for Advent but that is a distraction from the fact mia granted and maa is next!
Before the MAA it was the MIA won’t be granted
Before that it was the journal paper will not be published in a quality journal
Before that it was the Top Line Data won’t be reported or the results won’t be good
Before that it was the SAP
Before that it was the data lock
Before that it was …….
See a pattern?????
Yes, I see your point that DCVax is Apple-izing medical care/medicine, and I raise you that it is also Coke-ing the same, as in “everything goes better with Coke”
It’s all good, and the world will come to know it!
Eggsactly right!!!
No honest reason not to approve DCVax-L especially with production and supply chain/distribution worked out as well.
There is intelligent life out there after all.
Reminiscent of earlier days of this message board.
See, everyone doesn’t have to be a cheerleader to bring discourse worthy of scrutiny.
As an additional incentive, if the level and content can be maintained decently, even my silly posts will stop…. Nah
Nice find!
The news is spreading and like a geometric progression it builds slowly at first and then reaches the very rapid rate of increase!
Yes, the heading could be The Sh#t Happens Statement